MS Types: new definitions, new ways of thinking

Once upon a time, there was just a one-size-fits-all way to describe the disease known as multiple sclerosis (MS).  However, it was apparent that there was a wide range of individual courses. Some, but not all patients, suffered attacks.  Some remained relatively stable for many years, while others steadily worsened.  

A big advancement came in 1996 when an advisory committee of the National MS Society published a guideline for categorizing patients into one of four disease types: 

Food for the Brain 2015: videos posted online

Our second annual MS & Nutrition Workshop covered:

• The latest scientific findings on MS and nutrition
•  Practical advice regarding healthy eating and strategies for maintaining a healthy diet in the context of challenging MS symptoms
•  The importance of exercise in promoting an overall healthy lifestyle

MS Workshop: Optimize Your Day-to-Day Function

Learn how rehabilitation services can improve and preserve your mental and Physical well-being. Key topics will include cognitive and physical fatigue management, exercise and mobility, community resources, employment accommodations, stress management and practical approaches to improve function.

Saturday, March 5, 9:30 a.m. – 2:00 p.m.

Education Center in the Evergreen Surgery and Physician’s Building

12333 NE 130th Lane, Tan 100-101

Kirkland, WA

Registration for this workshop will begin in December 2015

Fall Prevention: Take Action!

Learn strategies for staying safe, active & independent

Each year, millions of adults aged 65 and older fall. Falls can cause moderate to severe injuries, such as hip fractures and head traumas, and can increase the risk of early death. Fortunately, falls are a public health problem that is largely preventable. (CDC). Learn about the risk factors and what you can do to prevent falls so that you can stay active and independent.

Neurological Exercise Group

Gentle stretch and strength exercises done in a chair and standing. For patients affected by neurological disorders such as Parkinson’s, Stroke and Multiple Sclerosis

Tuesdays, 1:00 – 1:50 p.m.

$20/four-week session (once per week)

EvergreenHealth is enrolling for overactive bladder in MS study

The *MIRROR STUDY* is now enrolling patients with MS and overactive bladder. 

The EvergreenHealth MS Center is looking for subjects with multiple sclerosis (MS) and overactive bladder (bladder urgency or loss of bladder control) to participate in a 12 week study that combines behavioral modification with pelvic floor muscle strengthening exercises and oral medication.

Contact: Research Coordinator, Shalom Kilcup @ 425-899-5369

EvergreenHealth MS Center @ 425-899-5350

MIRROR Research Study

Evergreen MS Center

Contact:  Shalom Kilcup

Phone: 425-899-5369

Trial to measure bone density in Gilenya™ patients

The MS Center at EvergreenHealth is now enrolling for MS-BMD - a trial to study the possible effects of disease modifying therapies on bone density in patients with Multiple Sclerosis. 

The MS-BMD trial will measure bone density changes in patients treated with Gilenya™ versus other FDA approved MS therapies or no therapy. This trial will last about 2 years and include at least 6 visits to our clinic.

Neuro-Nutrition Class

An interactive class and discussion group for people who live

with Parkinson’s Disease, MS and other neurologic conditions.

The focus of these classes will be to learn more about how to:

• Plan a good basic diet that provides the nutrition your body needs
• Understand the calories needed to achieve or maintain a reasonable weight
• Develop eating strategies to prevent GI issues like constipation and slow digestion
• Schedule meals for best medication action
• Protect your energy by planning and preparing meals

Safety study of drug to treat walking impairment in MS

ADS-AMT-MS201

Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment

Description

This is a multi-center, randomized, double-blind, placebo-controlled, 2-arm, parallel group study of ADS-5102 extended release (ER) capsules, an investigational formulation of amantadine, dosed once daily at bedtime for the treatment of walking impairment in MS.